|
|
|
|
GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males
GARDASIL[Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV)...
|
|
|
Understanding gastroenteritis in elderly residents of aged-care facilities
Early identification of outbreaks allows carers and public health agencies to reduce the burden of this disease Recently, serious outbreaks of foodborne gastroenteritis occurring in aged-care facilities (ACFs) have captured public and media...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
WHITEHOUSE STATION, N.J.-- (BUSINESS WIRE) -- ROTATEQ (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons ...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-Related Hospitalizations and Emergency Room Visits Combined in New
ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
(BUSINESS WIRE) -- ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--ROTATEQ (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons ...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
WHITEHOUSE STATION, N.J.-- (Business Wire) ROTATEQ (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons ...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related
ROTATEQ (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
- ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
- ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons (January through May of each year) in an...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--ROTATEQ (rotavirus vaccine, live, oral, pentavalent) reduced rotavirus-related hospitalizations and emergency room (ER) visits combined by 100 percent during the 2007 and 2008 rotavirus seasons ...
|
|
|
ROTATEQ(R) Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New
ROTATEQ Substantially Reduced Rotavirus-related Hospitalizations and Emergency Room Visits Combined in New U.S.Observational Study WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--ROTATEQ (rotavirus vaccine, live, oral, pentavalent) reduced...
|
|
|
Study data from A.C. Ike et al provide new insights into gastroenteritis epidemiology
- (NewsRx.com) -- New investigation results, 'Detection and characterization of sapoviruses in outbreaks of gastroenteritis in southwest Germany,' are detailed in a study published in Journal of Clinical Virology (see also Gastroenteritis...
|
|
|
Rotateq Receives WHO Pre-qualification
- ROTATEQ(R) (rotavirus vaccine, live, oral, pentavalent), the pentavalent rotavirus vaccine from Merck & Co., Inc., that helps prevent rotavirus gastroenteritis in infants and children, has been awarded pre-qualification status by...
|
